Harbin Pharmaceutical Group Co Ltd (600664) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.030x

Based on the latest financial reports, Harbin Pharmaceutical Group Co Ltd (600664) has a cash flow conversion efficiency ratio of -0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-192.19 Million ≈ $-28.12 Million USD) by net assets (CN¥6.41 Billion ≈ $937.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Harbin Pharmaceutical Group Co Ltd for the company's overall valuation and market capitalisation.

Harbin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Harbin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Harbin Pharmaceutical Group Co Ltd share price for real-time trading data and today's change.

Harbin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Review 600664 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
TP ICAP GROUP PLC LS -25 F:8D7	N/A
MGE Energy Inc NASDAQ:MGEE	0.047x
Mainova AG F:MNV6	-0.007x
Dlocal Ltd NASDAQ:DLO	0.168x
Neptune Insurance Holdings Inc. NYSE:NP	-0.124x
NuVista Energy Ltd. TO:NVA	0.040x
Hawkins Inc NASDAQ:HWKN	0.071x
Cembra Money Bank AG SW:CMBN	0.051x

Annual Cash Flow Conversion Efficiency for Harbin Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. Also see 600664 total assets for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.09 Billion ≈ $891.05 Million	CN¥792.50 Million ≈ $115.97 Million	0.130x	-25.68%
2023-12-31	CN¥5.42 Billion ≈ $793.53 Million	CN¥949.67 Million ≈ $138.97 Million	0.175x	+39.38%
2022-12-31	CN¥4.95 Billion ≈ $724.49 Million	CN¥622.09 Million ≈ $91.03 Million	0.126x	+441.93%
2021-12-31	CN¥4.42 Billion ≈ $646.86 Million	CN¥-162.44 Million ≈ $-23.77 Million	-0.037x	+79.87%
2020-12-31	CN¥3.99 Billion ≈ $583.65 Million	CN¥-728.15 Million ≈ $-106.55 Million	-0.183x	-280.76%
2019-12-31	CN¥5.94 Billion ≈ $869.62 Million	CN¥-284.94 Million ≈ $-41.70 Million	-0.048x	-143.47%
2018-12-31	CN¥6.28 Billion ≈ $919.10 Million	CN¥692.72 Million ≈ $101.37 Million	0.110x	+452.97%
2017-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥149.22 Million ≈ $21.84 Million	0.020x	-94.04%
2016-12-31	CN¥8.30 Billion ≈ $1.21 Billion	CN¥2.78 Billion ≈ $406.51 Million	0.335x	+50.91%
2015-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥1.66 Billion ≈ $242.91 Million	0.222x	+71.25%
2014-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥1.14 Billion ≈ $166.25 Million	0.130x	+702.39%
2013-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥141.64 Million ≈ $20.73 Million	0.016x	-74.96%
2012-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥557.83 Million ≈ $81.63 Million	0.064x	+1410.01%
2011-12-31	CN¥6.41 Billion ≈ $938.47 Million	CN¥-31.56 Million ≈ $-4.62 Million	-0.005x	-102.79%
2010-12-31	CN¥6.55 Billion ≈ $957.81 Million	CN¥1.15 Billion ≈ $168.67 Million	0.176x	-43.08%
2009-12-31	CN¥5.98 Billion ≈ $875.69 Million	CN¥1.85 Billion ≈ $270.95 Million	0.309x	+209.57%
2008-12-31	CN¥5.79 Billion ≈ $847.08 Million	CN¥578.59 Million ≈ $84.67 Million	0.100x	-22.30%
2007-12-31	CN¥5.05 Billion ≈ $739.58 Million	CN¥650.16 Million ≈ $95.14 Million	0.129x	-13.48%
2006-12-31	CN¥4.96 Billion ≈ $726.45 Million	CN¥738.08 Million ≈ $108.00 Million	0.149x	-13.82%
2005-12-31	CN¥4.39 Billion ≈ $642.77 Million	CN¥757.76 Million ≈ $110.88 Million	0.173x	+352.24%
2004-12-31	CN¥3.91 Billion ≈ $571.61 Million	CN¥149.01 Million ≈ $21.80 Million	0.038x	-60.58%
2003-12-31	CN¥3.13 Billion ≈ $457.96 Million	CN¥302.83 Million ≈ $44.31 Million	0.097x	-27.37%
2002-12-31	CN¥2.88 Billion ≈ $421.18 Million	CN¥383.44 Million ≈ $56.11 Million	0.133x	-40.95%
2001-12-31	CN¥2.68 Billion ≈ $391.86 Million	CN¥604.13 Million ≈ $88.40 Million	0.226x	-32.31%
2000-12-31	CN¥1.63 Billion ≈ $237.84 Million	CN¥541.70 Million ≈ $79.27 Million	0.333x	+14.09%
1999-12-31	CN¥1.48 Billion ≈ $216.01 Million	CN¥431.22 Million ≈ $63.10 Million	0.292x	+67.75%
1998-12-31	CN¥1.27 Billion ≈ $186.06 Million	CN¥221.41 Million ≈ $32.40 Million	0.174x	--

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.67 Billion

CN¥18.23 Billion CNY

Market Cap Rank

#5214 Global

#894 in China

Share Price

CN¥7.24

Change (1 day)

-2.16%

52-Week Range

CN¥2.93 - CN¥9.49

All Time High

CN¥9.49